cp wire

CP Wire Articles

Synlogic, Inc (Nasdaq: SYBX) a clinical stage company applying synthetic biology to beneficial microbes to develop novel, living medicines, announced on 3/6/19 the advancement of Synthetic Biotic... read more

Thu, 03/7/19 - 10:05 am
admin

Infant Bacterial Therapeutics AB announced on 3/5/19 the first distribution agreement for IBP-9414 with Megapharm Ltd. for the Israeli market and the Palestinian Authority’s territories. The... read more

Thu, 03/7/19 - 09:46 am
admin

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced on 3/7/19 the submission of a supplemental New Drug Application to the U.S. Food and Drug Administration (FDA) for... read more

Thu, 03/7/19 - 09:35 am
admin

Israeli healthcare-focused VC fund aMoon Partners has finalized $660 million in investor commitments for it second fund (aMoon II), making it the largest single fund in Israel. The fund, run by... read more

Wed, 03/6/19 - 09:40 am
admin

Xenetic Biosciences, Inc. (NASDAQ: XBIO), a clinical-stage biopharmaceutical company focused on the discovery, research and development of next-generation biologic drugs and novel orphan oncology... read more

Mon, 03/4/19 - 09:59 am
admin

On 3/4/19 Silk Road Medical Filed for an upcoming $86 Million IPO. The Sunnyvale, CA based company has introduced the TCAR procedure intended to reduce the risk embolic debris entering the brain... read more

Mon, 03/4/19 - 09:37 am
admin

Abpro, a biotechnology company dedicated to developing next-generation antibody therapeutics to improve the lives of patients with severe and life-threatening diseases, and NJCTTQ, a global... read more

Fri, 03/1/19 - 09:48 am
admin

BiomX Raises $32 Million in Series B Financing
BiomX Ltd., a microbiome company developing... read more

Thu, 02/28/19 - 09:20 pm
admin

Evotec AG (OTC PINK: EVTCY) (FSE: EVTA) (XETRA: EVT) announced on 2/28/19 that a promising small molecule from its multi-target alliance with Bayer has advanced into Phase II clinical development... read more

Thu, 02/28/19 - 10:35 am
admin

Blackstone Life Sciences today announced the launch of Anthos Therapeutics Inc. (“Anthos”), a new biopharmaceutical company focused on advancing next-generation targeted therapies for high-risk... read more

Wed, 02/27/19 - 10:14 am
admin

This morning, starting at approximately 10:15 AM ET, the United States Senate Finance Committee is holding a special hearing on drug pricing. Going before the Committee will be seven... read more

Tue, 02/26/19 - 10:20 am
admin

Xynomic Pharma, a clinical stage US-China oncology drug development company, and Bison Capital Acquisition Corp. (Nasdaq: BCAC) jointly announced on 2/25/19 the dosing of the first South Korean... read more

Tue, 02/26/19 - 10:02 am
admin

Alkermes plc (Nasdaq: ALKS) and Biogen Inc. (Nasdaq: BIIB) announced on 2/25/19 that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for... read more

Mon, 02/25/19 - 10:16 am
admin

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, announced on 2/25/19 that given the increasing viability of Valve-in-Valve (ViV) procedures, it has added new safety and... read more

Mon, 02/25/19 - 09:58 am
admin



Imbrium Therapeutics L.P., an operating subsidiary of Purdue Pharma L.P., in conjunction with Mundipharma EDO GmbH, announced on 2/21/19 that the U.S. Food and Drug Administration (FDA)... read more

Fri, 02/22/19 - 09:46 am
admin

On 2/21/19 Outlook Therapeutics filed for a $57 million offering in part to support its treatment for wet AMD (age related macular degeneration). The filing did not specify the number of shares to... read more

Thu, 02/21/19 - 10:49 am
admin

SkinBioTherapeutics to Seeking New CEO
On 2/14/19 SkinBioTherapeutics... read more

Wed, 02/20/19 - 02:23 pm
admin

Pfizer’s Xeljanz (tofacitinib), used to treat conditions such as rheumatoid arthritis and ulcerative colitis, has... read more
Wed, 02/20/19 - 11:50 am
admin

On 2/19/18 Kaleido Biosciences filed for a $120 Million IPO. The company will offer 4,761,905 shares of  common stock. The expected price is between $20 and $22 per share. The shares will be... read more

Tue, 02/19/19 - 09:53 am
admin

CStone Pharmaceuticals is seeking to raise $282 Million in its upcoming Hong Kong IPO. The company's investors include Boyu Capital, Sequoia Capital, Oriza Holdings, and GIC.

The company... read more

Mon, 02/18/19 - 09:48 am
admin

Pages



current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.